For instance, Microcolin H’s induction of autophagic cell death via PITPα/β inhibition [7], exemplifies a novel cancer targeting strategy, while Benzosceptrin C’s lysosomal degradation of PD-L1 [8] offers an innovative approach to overcoming immunotherapy resistance. Here, CD274 is linked to cancer.